longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

Amgen

AMGN

403.0401.04% ( -4.230 )
Trading: Oct 2, 13:40:48 (EDT)
Start trading
OverviewOverviewOptionsOptionsNewsNewsPostsPostsFinancialsFinancialsForecastForecastValuationValuationShareholdersShareholdersProfileProfileWeekly ReviewWeekly Review
LongbridgeAI
  • Ohio Rep. David Taylor Bought Up to $45K Worth of Amgen Stock

    benzinga_article·2 hours ago
    - Ohio Representative David Taylor filed a purchase of Amgen stock valued between $3,003 and $45,000, which occurred on September 22, 2026. - Over the past 3 years, Taylor has executed 231 stock trades totaling over $357,000, featuring notable transactions in companies like UnitedHealth Group, Eli Lilly, and Microsoft. - Under the STOCK Act of 2012, members of Congress are required to file Periodic Transaction Reports within specific timeframes to disclose individual stock trades to the public.
    AMGN-1.04%HD+0.34%
  • Amgen Inc Stock (AMGN) Closed Down by 3.38% on Oct 1: What Investors Need To Know

    TradingKey·21 hours ago
    AMGN-1.04%
  • S&P 500 Top Stock Gainers Today, 10/1/26

    Tip Ranks·22 hours ago
    - The S&P 500 closed 0.19% higher on October 1, 2026, driven by declining Treasury yields and rate hike expectations. - Energy emerged as the top-performing sector with a 1.92% gain as Brent crude rallied 4.5% to $ 102 per barrel following stalled U.S.-Iran negotiations. - The healthcare sector lagged with a 1.3% loss due to elevated Treasury yields and investor profit-taking in large-cap pharmaceutical stocks.
    AMGN-1.04%APA+0.06%
  • Walt Disney, Amgen Share Losses Lead Dow's 150-Point Fall

    MarketWatch Automated·1 day ago, 04:09 PM
    - The Dow Jones Industrial Average dropped 150 points, or 0.3%, on Thursday afternoon due to lower trading in several key stocks. - Walt Disney shares fell by $3.07, or 2.9%, and Amgen shares declined by $9.88, or 2.3%, together causing a roughly 77-point drag on the index. - Additional downward pressure on the index came from losses in Home Depot, American Express, and Apple.
    AMGN-1.04%DIS+1.11%
  • Amgen Inc. Stock Outperforms Competitors On Strong Trading Day

    MarketWatch Automated·2 days ago, 08:34 PM
    AMGN-1.04%
  • Biotech Stocks To Consider - September 29th

    Market Beat·Sep 29 at 04:02 PM
    AMGN-1.04%IOVA-0.28%
  • Scotiabank maintains Sector Outperform rating on Amgen, $500 price target

    TradingView·Sep 29 at 02:56 PM
    AMGN-1.04%
  • Eli Lilly Upgraded, Intel Downgraded: Updated Rankings on Top Blue-Chip Stocks

    InvestorPlace·Sep 28 at 07:13 PM
    - The financial author revised Stock Grader recommendations for 121 big blue-chip stocks based on institutional buying pressure and fundamental health. - Eli Lilly was upgraded to a strong rating, while Intel was downgraded among several other major companies. - Investors are encouraged to use the proprietary stock screening tool and subscribe to premium services for updated portfolio rankings.
    ACGL-1.36%AEG-0.06%
  • Amgen Stock Forecast: Sjögren’s Trial Success Tests AMGN’s Pipeline Outlook

    TradingKey·Sep 28 at 03:01 PM
    AMGN-1.04%
  • 2 Healthcare Stocks That Just Delivered Great News for Investors

    Motley Fool·Sep 26 at 08:04 PM
    VRTX-0.31%AMGN-1.04%
  • Weekly Recap | Amgen +7.51%, Phase 3 Sjogren's trial hits endpoint

    Weekly Review·Sep 26 at 05:57 AM
    AMGN-1.04%
  • How Phase 3 Sjögren’s Results At Amgen (AMGN) Has Changed Its Investment Story

    Simplywall·Sep 26 at 02:04 AM
    AMGN-1.04%
  • Dow Stock to Target After Holding Key Support

    Schaeffers·Sep 25 at 06:55 PM
    AMGN-1.04%
  • Biotech Stocks To Research - September 25th

    Market Beat·Sep 25 at 04:02 PM
    VKTX-1.31%RVMD+0.32%
  • Amgen reports a Phase 3 win with Sjögren’s drug candidate

    biopharmadive·Sep 24 at 02:36 PM
    AMGN-1.04%